Related Experiment Video

Updated: May 10, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Advanced glycation end products and diabetic retinopathy

M Chen1, T M Curtis, A W Stitt

  • 1Centre for Vision & Vascular Science, Queen’s University Belfast, Northern Ireland, UK.

Current Medicinal Chemistry
|June 11, 2013
PubMed

Insights

Advanced glycation and lipoxidation end products (AGEs/ALEs) drive diabetic retinopathy (DR) pathology. Inhibiting the AGE-RAGE system shows therapeutic potential for treating DR.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Biochemistry

Background:

  • Diabetic retinopathy (DR) involves complex pathogenesis influenced by systemic abnormalities and diabetes-induced retinal changes.
  • Advanced glycation end products (AGEs) and advanced lipoxidation end products (ALEs) are key modifications contributing to retinal damage in diabetes.
  • These AGEs/ALEs play significant roles in initiating and progressing diabetic eye disease pathology.

Purpose of the Study:

  • To review the formation and accumulation of AGEs and ALEs in the diabetic retina.
  • To discuss the impact of AGEs/ALEs on retinal cell function.
  • To evaluate therapeutic strategies targeting the AGE-RAGE system for DR treatment.

Main Methods:

  • Literature review focusing on AGE/ALE formation in diabetic retinopathy.
  • Analysis of the role of AGEs/ALEs in retinal cell dysfunction.
  • Evaluation of inhibitors of the AGE-RAGE pathway and their clinical relevance.

Main Results:

  • AGEs and ALEs accumulate in the diabetic retina, contributing to pathological processes.
  • These modifications negatively affect retinal cell function, exacerbating DR.
  • Inhibitors of the AGE-RAGE system demonstrate potential therapeutic benefits for DR.

Conclusions:

  • AGE/ALE accumulation is a critical factor in diabetic retinopathy pathogenesis.
  • Targeting the AGE-RAGE pathway represents a promising therapeutic avenue for managing DR.
  • Further research into AGE-RAGE inhibitors could lead to novel treatments for diabetic eye disease.

More Related Videos

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish05:49

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish

Published on: May 5, 2021

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...